The Clinical Pharmacology Implementation Consortium (CPIC) and the Dutch Pharmacology Working Group (DPWG) of the Royal Netherlands Society for Pharmaceutical Progress have shown that individuals with decreased function of the organic anion-transporting polypeptide 1B1 (OATP1B1) liver transporter enzyme (encoded by the SLCO1B1 gene) are at increased risk of rhabdomyolysis (20). Here, SLCO1B1 is linked to rhabdomyolysis.